Inventor · disambiguated record
Andrew M. Blumenfeld
Also filed as: BLUMENFELD ANDREW · BLUMENFELD ANDREW M
28 granted patents·31 pending applications·473 citations·filing 2003–2025
97Inventor score
Files withALLERGAN INC26BLUMENFELD ANDREW M17ALLERGAN PHARMACEUTICALS INT LTD5AEON BIOPHARMA INC3AEON BIOPHARMA SUB INC3
Top patents by PatentIndex Score
59 records- 0198US8609112B2Botulinum toxin treatments of depressionALLERGAN INC·Filed 2013·Granted Dec 17, 2013·37 cites·15 claims
- 0297US9248168B2Suture line administration technique using botulinum toxinsALLERGAN INC·Filed 2013·Granted Feb 2, 2016·23 cites·20 claims
- 0397US8846622B2Targeted delivery of botulinum toxin to the sphenopalatine ganglionALLERGAN INC·Filed 2013·Granted Sep 30, 2014·27 cites·19 claims
- 0497US8609113B2Botulinum toxin treatments of depressionALLERGAN INC·Filed 2013·Granted Dec 17, 2013·31 cites·15 claims
- 0597US7655244B2Targeted delivery of botulinum toxin for the treatment and prevention of trigeminal autonomic cephalgias, migraine and vascular conditionsALLERGAN INC·Filed 2005·Granted Feb 2, 2010·47 cites·11 claims
- 0696US9827297B2Suture line administration technique using botulinum toxinsALLERGAN INC·Filed 2016·Granted Nov 28, 2017·14 cites·15 claims
- 0795US10220079B2Suture line administration technique using botulinum toxinsALLERGAN INC·Filed 2017·Granted Mar 5, 2019·11 cites·20 claims
- 0895US8617571B2Suture line administration technique using botulinum toxinBLUMENFELD ANDREW M·Filed 2008·Granted Dec 31, 2013·22 cites·6 claims
- 0995US8617572B2Botulinum toxin treatments of depressionBLUMENFELD ANDREW M·Filed 2011·Granted Dec 31, 2013·16 cites·7 claims
- 1095US8241641B2Targeted delivery of botulinum toxin for the treatment and prevention of trigeminal autonomic cephalgias, migraine and vascular conditionsBLUMENFELD ANDREW M·Filed 2009·Granted Aug 14, 2012·32 cites·16 claims
- 1195US7981433B2Targeted delivery of botulinum toxin to the sphenopalatine ganglionALLERGAN INC·Filed 2010·Granted Jul 19, 2011·27 cites·19 claims
- 1295US7749515B2Targeted delivery of botulinum toxin to the sphenopalatine ganglionALLERGAN INC·Filed 2008·Granted Jul 6, 2010·26 cites·15 claims
- 1394US8734810B2Botulinum toxin treatments of neurological and neuropsychiatric disordersBLUMENFELD ANDREW M·Filed 2004·Granted May 27, 2014·48 cites·18 claims
- 1493US10064921B2Botulinum toxin treatments of neurological and neuropsychiatric disordersALLERGAN INC·Filed 2017·Granted Sep 4, 2018·10 cites·15 claims
- 1593US8530425B2Targeted delivery of botulinum toxin to the sphenopalatine ganglionBLUMENFELD ANDREW M·Filed 2011·Granted Sep 10, 2013·17 cites·18 claims
- 1692US10111938B2Injection paradigm for administration of botulinum toxinsALLERGAN INC·Filed 2016·Granted Oct 30, 2018·10 cites·18 claims
- 1791US8603983B2Targeted delivery of botulinum toxin for the treatment and prevention of trigeminal autonomic cephalgias, migraine and vascular conditionsBLUMENFELD ANDREW M·Filed 2012·Granted Dec 10, 2013·14 cites·3 claims
- 1890US9238061B2Botulinum toxin treatment of anxiety and bipolar disordersALLERGAN INC·Filed 2013·Granted Jan 19, 2016·12 cites·20 claims
- 1989US10729751B2Injection paradigm for administration of botulinum toxinsALLERGAN INC·Filed 2018·Granted Aug 4, 2020·5 cites·29 claims
- 2088US10874722B2Suture line administration technique using botulinum toxinsALLERGAN INC·Filed 2019·Granted Dec 29, 2020·3 cites·20 claims
- 2187US8383103B2Botulinum toxin compositions and methodsALLERGAN INC·Filed 2008·Granted Feb 26, 2013·12 cites·15 claims
- 2284US10456455B2Treatment of psychological traumaALLERGAN INC·Filed 2017·Granted Oct 29, 2019·4 cites·10 claims
- 2384US2023263869A1Suture line administration technique using botulinum toxinsALLERGAN INC·Filed 2022·Application pending·0 cites
- 2483US8697066B2Botulinum toxin compositions and methodsALLERGAN INC·Filed 2013·Granted Apr 15, 2014·6 cites·10 claims
- 2580US11826405B2Neurotoxin compositions for use in treating headacheAEON BIOPHARMA INC·Filed 2020·Granted Nov 28, 2023·1 cites·30 claims
- 2680US11077174B2Treatment of psychological traumaALLERGAN INC·Filed 2019·Granted Aug 3, 2021·2 cites·7 claims
- 2780US8992941B2Method for treatment of esophageal spasmBLUMENFELD ANDREW M·Filed 2012·Granted Mar 31, 2015·4 cites·10 claims
- 2880US8388952B2Botulinum toxin compositions and methodsGAYLIS FRANKLIN D·Filed 2008·Granted Mar 5, 2013·8 cites·18 claims
- 2975US9764009B2Treatment of psychological traumaABEL KENTON B·Filed 2012·Granted Sep 19, 2017·4 cites·2 claims
- 3075US2021121543A1Suture line administration technique using botulinum toxinsALLERGAN INC·Filed 2020·Application pending·0 cites
- 3173US2024050540A1Neurotoxin compositions for use in treating headacheAEON BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 3271US2014205590A1Botulinum toxin treatments of neurological and neuropsychiatric disordersALLERGAN INC·Filed 2014·Application pending·0 cites
- 3370US2023158128A1Cgrp antagonists and clostridial derivatives for the treatment of neuropsychiatric and neurological disordersALLERGAN PHARMACEUTICALS INT LTD·Filed 2022·Application pending·0 cites
- 3469US2020360492A1Injection paradigm for administration of botulinum toxinsALLERGAN INC·Filed 2020·Application pending·0 cites
- 3569US2023105611A1Combination therapy with cgrp antagonists and clostridial derivativesALLERGAN PHARMACEUTICALS INT LTD·Filed 2022·Application pending·0 cites
- 3668US2024216486A1Injectable botulinum toxin methods for treating headachesREVANCE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3766US2025134970A1Neurotoxin compositions for use in treating headacheAEON BIOPHARMA SUB INC·Filed 2025·Application pending·0 cites
- 3861US2020030415A1Combination therapy with cgrp antagonists and clostridial derivativesALLERGAN PHARMACEUTICALS INT LTD·Filed 2019·Application pending·0 cites
- 3961US2018369348A1Botulinum toxin treatments of neurological and neuropsychiatric disordersALLERGAN INC·Filed 2018·Application pending·0 cites
- 4060US2024252603A1Neurotoxin compositions for use in treating headacheAEON BIOPHARMA SUB INC·Filed 2022·Application pending·0 cites
- 4159US2024252754A1Single-use neurotoxin formulations and packagingAEON BIOPHARMA SUB INC·Filed 2022·Application pending·0 cites
- 4259US2021121541A1CGRP Antagonists and Clostridial Derivatives for the Treatment of Neuropsychiatric and Neurological DisordersALLERGAN PHARMACEUTICALS INT LTD·Filed 2020·Application pending·0 cites
- 4357US2023210963A1Injectable botulinum toxin methos for treating headachesREVANCE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4457US2025064906A1Neurotoxin compositions for use in treating digestive disordersAEON BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 4553US2020383983A1Cgrp antagonists for the treatment of medication overuse headache, post-traumatic headache, post-concussion syndrome and vertigoALLERGAN SALES LLC·Filed 2020·Application pending·0 cites
- 4652US2021128724A1Cgrp antagonists and clostridial derivatives for the treatment of cortical spreading depression associated disordersALLERGAN PHARMACEUTICALS INT LTD·Filed 2020·Application pending·0 cites
- 4751US2010124559A1Early Treatment and Prevention of Increased Muscle TonicityALLERGAN INC·Filed 2009·Application pending·0 cites
- 4850US2004115139A1Botulinum toxin dental therapies and proceduresALLERGAN INC·Filed 2003·Application pending·0 cites
- 4949US2014140983A1Method for treatment of autonomic nervous system disordersBLUMENFELD ANDREW M·Filed 2012·Application pending·0 cites
- 5049US2006018844A1Botulinum toxin dental therapy for angular cheilosisALLERGAN INC·Filed 2005·Application pending·0 cites
Showing the top 50 of 59 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Andrew M. Blumenfeld files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →